Veracyte, Inc.
HalioDx is an immuno-oncology diagnostic company providing physicians with first-in-class Immune-based diagnostic solutions to guide cancer care and contribute to precision medicine in the era of immuno-oncology. With CLIA-certified laboratories and compliant facilities in Europe and in the US, HalioDx is also executing biomarker studies and companion diagnostic assay development in conformity with regulations and in partnership with biopharmaceutical companies.